Previous 10 | Next 10 |
When you’re investing in penny stocks, what’s your goal? Why are you buying the stock you’re looking at? You can be one of the “AMC Apes” that focus on “never” selling. While AMC Entertainment ( NYSE:AMC ) has taken on a life of its own, ...
Gainers: Chembio Diagnostics (CEMI) +195%, NeuroMetrix (NURO) +143%, TRxADE HEALTH (MEDS) +40%, TransCode Therapeutics (RNAZ) +24%, Cassava Sciences (SAVA) +20%.Losers: NeuroBo Pharmaceuticals (NRBO) -19%, Healthcare Services (HCSG) -11%, ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chipotle Mexican Grill (NYSE: CMG ) stock is getting a boost on Wednesday thanks to a few bits of news from the fast-food company. Source: Northfoto / Shutterstock.com Here are all the latest details on what h...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Chembio Diagnostics (NASDAQ: CEMI ) surged more than 100% in this morning’s premarket trading after the company revealed a multi-million dollar order for its Covid-19 rapid antigen tests. The CEMI sto...
Chembio Diagnostics (CEMI) +93% on receiving $28.3M purchase order from Bio-Manguinhos for DPP SARS-CoV-2. Antigen Tests in BrazilLexaria Bioscience (LEXX) +42% as DehydraTECH significantly enhances delivery of Colchicine in study VIRAL-A20-3.PainReform (PRFX) +27%.Xtant Medica...
With earnings season in full swing, there’s plenty to watch in the stock market today. For us, it’s all about penny stocks, and you should be watching these cheap stocks too. Why? Let me paint the picture. You find one of “these” stocks under $5. Let’s say...
legna69/iStock via Getty Images Chembio Diagnostics (CEMI) has gained ~96.1% in early trading after the company announced that it received a purchase order valued at $28.3M for the delivery of Chembio’s DPP SARS-CoV-2 antigen test to support the containment of the p...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! We’re halfway through the week now but there’s no time to slack of yet. Let’s get ready for another busy day of trading with the pre-market stock movers for Wednesday! Source:...
HAUPPAUGE, N.Y., July 20, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a $28.3 million purchase order from Bio-Manguinhos for the purchase of Chembio...
Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...
News, Short Squeeze, Breakout and More Instantly...
Chembio Diagnostics Inc. Company Name:
CEMI Stock Symbol:
NASDAQ Market:
Chembio Diagnostics Inc. Website:
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...
MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 ...